Allogene Therapeutics, Inc. - ALLO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$653.8M

QoQ value delta ($000)

+$208M (+46.65%)

Implied price effect (QoQ)

-13.63%

Total shares

313,529,641

QoQ shares delta

+128,871,623 (+69.79%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 211 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BlackRock, Inc.	62,705	30,146,963	0.0%
PFIZER INC	46,928	22,032,040	27.55%
Frazier Life Sciences Management, L.P.	46,689	22,446,668	1.02%
STATE STREET CORP	39,573	19,025,826	0.0%
TPG GP A, LLC	38,929	18,716,306	0.78%
Sio Capital Management, LLC	27,712	13,323,431	4.59%
PRIMECAP MANAGEMENT CO/CA/	27,296	13,123,440	0.02%
VANGUARD CAPITAL MANAGEMENT LLC	25,306	12,166,636	0.0%
FMR LLC	24,978	12,009,043	0.0%
CITADEL ADVISORS LLC	21,264	10,223,370	0.0%
TWO SIGMA INVESTMENTS, LP	16,191	7,784,348	0.01%
GEODE CAPITAL MANAGEMENT, LLC	14,666	7,049,328	0.0%
GOLDMAN SACHS GROUP INC	12,789	6,148,959	0.0%
GordonMD Global Investments LP	11,019	5,298,000	5.33%
MARSHALL WACE, LLP	10,598	5,095,408	0.01%
Patient Square Capital LP	10,504	5,050,000	1.63%
Aberdeen Group plc	10,403	5,001,752	0.01%
MILLENNIUM MANAGEMENT LLC	10,075	4,843,889	0.0%
D. E. Shaw & Co., Inc.	9,798	4,710,735	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	9,651	4,639,283	0.0%
MORGAN STANLEY	9,380	4,509,962	0.0%
Woodline Partners LP	9,361	4,500,624	0.03%
Candriam S.C.A.	9,010	4,336,296	0.04%
VANGUARD PORTFOLIO MANAGEMENT LLC	8,761	4,212,078	0.0%
RENAISSANCE TECHNOLOGIES LLC	7,975	3,834,312	0.01%